Consistently, inhibiting Yki activity by co-expressing wts or hpo significantly impeded the synergistic tumor-promoting effect between RasV12 and Toll activation (Fig. 4C,D), and restored the pupation defects (Fig. 4E). This evidence concerns the gene TLR4 and neoplasm.